Aspirin cuts colon cancer death risk: U.S. study

	Tweet

Taking aspirin not only can help keep colon cancer from coming back, but it also can lower the risk of dying from the disease, U.S. researchers said on Tuesday.

Aspirin already occupies a prominent spot in many medicine cabinets. Daily use of low-dose aspirin can stave off heart attacks and strokes, as well as chase away aches and pains.

Other studies have found it can reduce the risk of developing colon cancer. The latest study, published in the Journal of the American Medical Association, shows it can prevent colorectal cancer deaths.

Dr. Andrew Chan of Massachusetts General Hospital and Harvard Medical School in Boston and colleagues studied aspirin use in 1,279 men and women with colorectal cancer that had not spread to other parts of the body.

They found that people who took aspirin regularly after their diagnosis were nearly 30 percent less likely to die from their cancer than people who did not take aspirin. These people also were 21 percent less likely to die for any reason while they were in the study lasting more than two decades.

“These results suggest that aspirin may influence the biology of established colorectal tumors in addition to preventing their occurrence,” Chan said in a statement.

Chan said aspirin likely works by blocking the enzyme cyclooxygenase2, or COX-2, which promotes inflammation and cell division. Many tumors make an abundance of COX-2, he said.

Despite its benefits, aspirin can cause serious bleeding in the stomach. The team said further study in carefully controlled clinical trials should be done before the drug could be recommended for routine use by colon cancer patients.

Colorectal cancer is the second-leading cancer killer in the United States behind lung cancer. It will kill an estimated 50,000 Americans this year, according to the U.S. National Cancer Institute.

CHICAGO (Reuters)

RELATED STORIES:
Study examines quality of colonoscopy reporting and performance   Cigarette smoking increases colorectal cancer risk   Cocoa could prevent intestinal pathologies such as colon cancer   New report says racial gap growing in colorectal cancer   New function for colon cancer gene found   Post-Treatment Diet Patterns Explored in Colorectal Cancer Patients   Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival   Novel feces analysis may help detect colon cancer   Statin drugs may lower colon cancer risk - study   Experimental drug slows tumor growth   Hydrophobic proteins: Potential biomarkers for colorectal cancer   Women fare better than men with metastatic colorectal cancer—are hormones helping?   ‘Cross-talk’ Mechanism Contributes to Colorectal Cancer   Colon cancer risk in women does not seem to be reduced by physical activity   Colorectal cancer attitudes vary by ethnicity   Most Adults Don’t Realize Activity Lowers Colon Cancer Risk   Can a Cholesterol Drug Prevent Colon Cancer?   Major Advance in Search for Genes Associated with Colon Cancer   Virtual colonoscopy is an accurate screening method for colorectal cancer   Genetic ID of Marker in Lymph Nodes May be Linked to Colorectal Cancer Recurrence Risk   NSAIDs tied to reduced death after colon cancer   Protein Levels Indicate Risk of Death in Some Colorectal Cancer Patients

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]